Nuclear reprogramming factor
S Yamanaka, K Takahashi, K Okita - US Patent 8,048,999, 2011 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
38162968&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
38162968&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Oct3/4, Klf4, c-Myc and Sox2 produce induced pluripotent stem cells
S Yamanaka, K Takahashi - US Patent 8,058,065, 2011 - Google Patents
The present invention relates to a nuclear reprogramming factor having an action of
reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell …
reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell …
Nuclear reprogramming factor and induced pluripotent stem cells
S Yamanaka, K Takahashi… - US Patent App. 12 …, 2009 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
42983923&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
42983923&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Induced pluripotent stem cells produced using reprogramming factors and a rho kinase inhibitor or a histone deacetylase inhibitor
K Sakurada, H Masaki, T Ishikawa… - US Patent …, 2012 - Google Patents
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C (= O) C (NC (= O)
C (CCC (N)= O) NC (= O) C (CCC (O)= O) NC (= O) C (C (C) C) NC (= O) C (NC (= O) CN) C …
C (CCC (N)= O) NC (= O) C (CCC (O)= O) NC (= O) C (C (C) C) NC (= O) C (NC (= O) CN) C …
Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
S Yamanaka, K Takahashi, K Okita - US Patent 8,129,187, 2012 - Google Patents
The present invention relates to a nuclear reprogramming factor having an action of
reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell …
reprogramming a differentiated somatic cell to derive an induced pluripotent stem (iPS) cell …
Nuclear reprogramming factor and induced pluripotent stem cells
S Yamanaka, K Takahashi… - US Patent App. 12 …, 2009 - Google Patents
2009-10-30 Assigned to KYOTO UNIVERSITY reassignment KYOTO UNIVERSITY
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE FROM 36 …
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE FROM 36 …
Multipotent/Pluripotent Cells and Methods
K Sakurada, H Masaki, T Ishikawa… - US Patent App. 12 …, 2009 - Google Patents
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C (= O) C (NC (= O)
C (CCC (N)= O) NC (= O) C (CCC (O)= O) NC (= O) C (C (C) C) NC (= O) C (NC (= O) CN) C …
C (CCC (N)= O) NC (= O) C (CCC (O)= O) NC (= O) C (C (C) C) NC (= O) C (NC (= O) CN) C …
Human pluripotent stem cells induced from undifferentiated stem cells derived from a human postnatal tissue
K Sakurada, H Masaki, T Ishikawa… - US Patent App. 12 …, 2011 - Google Patents
To establish human pluripotent stem cells having properties close to human ES cells
comprising the genome of the patient perse that can circumvent immunological rejection of …
comprising the genome of the patient perse that can circumvent immunological rejection of …
Multipotent/pluripotent cells and methods
K Sakurada, H Masaki, T Ishikawa… - US Patent App. 12 …, 2010 - Google Patents
SKVWSNOLUIYQFD-YQUYJWMZSA-N N-[(2S, 3R, 4R, 5R, 6R)-2-[(2R, 3R, 4S, 5S, 6R)-2-
[(2R, 3R, 4R, 5R, 6S)-6-[(2R, 3S, 4R, 5R, 6R)-6-[(E, 2S, 3R)-2-formamido-3-hydroxyoctadec …
[(2R, 3R, 4R, 5R, 6S)-6-[(2R, 3S, 4R, 5R, 6R)-6-[(E, 2S, 3R)-2-formamido-3-hydroxyoctadec …
Providing iPSCs to a customer
K Sakurada - US Patent 9,213,999, 2015 - Google Patents
6,660,514 B1 12/2003 Zolotukhin et al. 2010. 0233804 A1 9, 2010 Zhou 6,773,920 B1
8/2004 Dalby et al. 2010/0240090 A1 9/2010 Sakurada et al. 6,833,269 B2 12/2004 …
8/2004 Dalby et al. 2010/0240090 A1 9/2010 Sakurada et al. 6,833,269 B2 12/2004 …